Aureus Pharma extends collaboration with Sanofi-Aventis
Aureus Pharma, a provider of knowledge management solutions to aid discovery in the life sciences industry, announced that sanofi-aventis has become its first customer for the company's recently released AurSCOPE® Ion Channel database. This agreement extends the collaboration between Aureus Pharma and sanofi-aventis which already covered other Aureus databases. The financial terms of the agreement were not disclosed.
This new database gives researchers access to information on all major ion channels already described in scientific literature, allowing the identification, validation and prioritization of new targets and ligands for drug discovery. Sanofi-aventis plans to use the AurSCOPE-Ion Channel database to help researchers speed up its discovery process in a number of fields.
The agreement means that Aureus Pharma is successfully expanding its range of knowledge management tools, and increasing market penetration. The company already has collaboration agreements with other life science companies including Roche.
The market importance of ion channels as a class of targets for drug discovery is growing. They play a crucial role in all functions in the human body and are targets in a wide variety of diseases including cystic fibrosis, epilepsy and arrhythmia. They remain one of the less exploited therapeutic target areas studied today, one of the reasons why Aureus Pharma has developed its AurSCOPE to accelerate research in this field.
Most read news
Topics
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.